Pay in 4 interest-free payments of $5.04 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
doi: 10.1038/s41574-024-01047-y, 43
In clinical trials of Wegovy, 7% of people reported an increase in burping while on the medication
Dose-pen formats , reconstitution accuracy advantages over vial-and-syringe workflows for repeat-dose research
Allegations against Novo Nordisk include that Wegovy (generic name semaglutide) causes gastrointestinal issues, vision loss (NAION), and now blood clot-related side effects, which the company does not properly warn patients about
At the wholesale acquisition cost of Wegovy ($1,349.02 per month as of January 2026), covering all eligible enrollees would cost approximately $12.9 billion annually
US$ 28.42
US$ 24.72
US$ 27.42
US$ 25.51
US$ 25.05
US$ 25.85
